Review of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine system
- PMID: 19920976
- PMCID: PMC2770406
- DOI: 10.2147/ppa.s3464
Review of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine system
Abstract
The levonorgestrel-containing intrauterine system is an extremely effective, reversible and safe form of long-term yet reversible birth control. In view of its efficacy, it is a safer alternative to permanent contraceptive methods such as sterilization. It is especially useful in situations where use of estrogen-containing contraceptives is contraindicated. While menstrual disturbances are a common side effect, proper counseling improves compliance. In addition to its contraceptive effect, the levonorgestrel intrauterine system offers potential therapeutic benefits in other clinical contexts, including menorrhagia, symptomatic fibroids, endometriosis, and endometrial protection.
Keywords: contraception; intrauterine device; levonorgestrel intrauterine device.
Similar articles
-
The levonorgestrel-releasing intrauterine system: an updated review of the contraceptive and noncontraceptive uses.Clin Obstet Gynecol. 2007 Dec;50(4):886-97. doi: 10.1097/GRF.0b013e318159c0d9. Clin Obstet Gynecol. 2007. PMID: 17982331 Review.
-
A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.Drug Saf. 1996 Dec;15(6):430-40. doi: 10.2165/00002018-199615060-00006. Drug Saf. 1996. PMID: 8968696 Review.
-
Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.Contraception. 1995 Nov;52(5):269-76. doi: 10.1016/0010-7824(95)00210-2. Contraception. 1995. PMID: 8585882 Review.
-
Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.J Obstet Gynaecol Can. 2016 Feb;38(2):182-222. doi: 10.1016/j.jogc.2015.12.002. Epub 2016 Feb 26. J Obstet Gynaecol Can. 2016. PMID: 27032746 English, French.
-
Hormonal intrauterine devices.Ann Med. 1993 Apr;25(2):143-7. doi: 10.3109/07853899309164158. Ann Med. 1993. PMID: 8489751
Cited by
-
Comparing options for females seeking permanent contraception in high resource countries: a systematic review.Reprod Health. 2021 Jul 20;18(1):154. doi: 10.1186/s12978-021-01201-z. Reprod Health. 2021. PMID: 34284794 Free PMC article.
-
Long-acting, progestin-based contraceptives and risk of breast, gynecological, and other cancers.J Natl Cancer Inst. 2025 May 1;117(5):1046-1055. doi: 10.1093/jnci/djae282. J Natl Cancer Inst. 2025. PMID: 39805314 Free PMC article.
-
The Effect of the Levonorgestrel-Releasing Intrauterine System on Myometrial Blood Flow in Patients With Heavy Menstrual Bleeding.Cureus. 2024 Aug 12;16(8):e66712. doi: 10.7759/cureus.66712. eCollection 2024 Aug. Cureus. 2024. PMID: 39262516 Free PMC article.
-
The Impact of Hormonal Contraceptive Use on Serotonergic Neurotransmission and Antidepressant Treatment Response: Results From the NeuroPharm 1 Study.Front Endocrinol (Lausanne). 2022 Mar 11;13:799675. doi: 10.3389/fendo.2022.799675. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35360055 Free PMC article.
-
Contraception counseling for women with premenstrual dysphoric disorder (PMDD): current perspectives.Open Access J Contracept. 2019 Sep 20;10:27-39. doi: 10.2147/OAJC.S183193. eCollection 2019. Open Access J Contracept. 2019. PMID: 31572029 Free PMC article.
References
-
- Abou-Setta AM, Al-Inany HG, Farquhar CM. Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery. Cochrane Database of Systematic Reviews. 2006;(Issue 4) - PubMed
-
- Andersson K, Batar I, Rybo G. Return to fertility after removal of a levonorgestrel-releasing intrauterine device and Nova-T. Contraception. 1992;46:575–84. - PubMed
-
- Andersson K, Odlind V, Rybo G. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use. A randomized comparative trial. Contraception. 1994;49:56–72. - PubMed
-
- Anderson JK, Rybo G. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. Br J Obstet Gynaecol. 1990;97:690–4. - PubMed
-
- Backman T, Huhtala S, Luoto R, et al. Advance information improves user satisfaction with the levonorgestrel intrauterine system. Obstet Gynecol. 2002;99:608–13. - PubMed
LinkOut - more resources
Full Text Sources